MetaModix
Metamodix is dedicated to reducing the human and financial costs of metabolic diseases by developing cost-effective, drug-free, nonsurgical device therapies. Their first product, the EndoSleeve, offers a safer and more cost-effective alternative to traditional bariatric surgery for treating Type 2 Diabetes, Obesity, and NASH, aiming to improve patient outcomes and reduce healthcare costs.
Industries
Nr. of Employees
small (1-50)
MetaModix
Patents
Systems and methods for anchoring and restraining gastrointestinal prostheses
US-11737900-B2
View Details
Systems and methods for anchoring and restraining gastrointestinal prostheses
US-11737900-B2
View DetailsProducts
Endoluminal intestinal sleeve implant
An implantable gastrointestinal sleeve designed to anchor at the stomach–small intestine junction and channel food to bypass part of the proximal small intestine, intended to alter intestinal signaling associated with metabolic disease outcomes.
Endoluminal intestinal sleeve implant
An implantable gastrointestinal sleeve designed to anchor at the stomach–small intestine junction and channel food to bypass part of the proximal small intestine, intended to alter intestinal signaling associated with metabolic disease outcomes.
Services
Online procedural animations and videos demonstrating implantation and retrieval of the endoluminal sleeve implant for clinician training.
Online procedural animations and videos demonstrating implantation and retrieval of the endoluminal sleeve implant for clinician training.
Expertise Areas
- Endoscopic bariatric/metabolic device development
- Minimally invasive endoscopic procedural workflows
- Medical device regulatory submissions and quality systems
- Clinical research for device therapies
Key Technologies
- Endoluminal sleeve implants
- Endoscopic delivery and retrieval systems
- Anchor fixation mechanisms at the pyloric junction
- Minimally invasive outpatient procedure protocols